ABSTRACT: Different sources of mesenchymal stromal cells can be considered for regenerative medicine applications. Here we analyzed human adipose-derived stromal cells from infrapatellar fat pad (IFPSC) of osteoarthritis patients, representing a very interesting candidate for cartilage regeneration. No data are available concerning IFPSC stability after in vitro expansion. Indeed, replicative potential and multipotency progressively decrease during culture passages while DNA damage and cell senescence increase, thus possibly affecting clinical applications. To investigate whether in vitro expansion influences the genetic stability and replicative senescence of IFPSC, we performed long-term cultures and comparatively analyzed cells at different culture passages. Stromal vascular fraction was harvested from infrapatellar fat pad of 11 osteoarthritis patients undergoing knee replacement surgery. Cell recovery, growth kinetics, surface marker profile, and differentiation ability in inductive culture conditions were recorded. Genetic integrity maintenance was estimated by microsatellite instability analysis and mismatch repair gene expression, whereas telomere length and telomerase activity were assessed to evaluate replicative senescence. Anchorage-dependent growth was tested by soft agar culture. IFPSC displayed a phenotype similar to mesenchymal stromal cells from subcutaneous fat and showed differentiation ability. No microsatellite instability was documented even at advanced culture times in accordance to a sustained expression of mismatch repair genes, thus highlighting stability of short repeated sequences in the genome. No significant telomere attrition nor telomerase activity were documented during culture and cells did not lose anchorage-dependent growth ability. The presented data support the suitability and safety of in vitro expanded IFPSC from osteoarthritis patients for applications in regenerative medicine approaches. ß
Mesenchymal stromal cells hold great promise for regenerative therapies due to their trophic, paracrine, and immunomodulatory activities and to their multipotency. They have been isolated and characterized from several tissues like bone-marrow, fat, periosteum, synovial fluid, cord blood, etc. 1 Adipose tissue is an interesting source of adult mesenchymal stromal cells for its abundance, absence of ethical limitations, and easy accessibility. Adiposederived mesenchymal stromal cells (ASC) are located in the stromal vascular fraction (SVF) of adipose tissue and represent up to 5% of SVF nucleated cells, an average 500-fold higher rate of precursors compared to bone marrow. 2 Under inductive culture conditions ASC are able to differentiate into adipocytes, chondrocytes, and osteoblasts.
They display a paracrine activity through secretion of cytokines and growth factors, 3 they exert antiapoptotic and chondroprotective role in co-culture 4 and attract host mesenchymal cells in the lesion site. 5 These features make them an ideal candidate for cellular therapies, particularly for the treatment of osteo-articular pathologies. 5 In this study, we focused our attention on human Infrapatellar Fat Pad (IFP) from OA patients as source of ASC for the potential treatment of damaged/ diseased articular cartilage. IFP is a joint tissue with a recently recognized active role during osteoarthritis (OA) development. 6 It is easy accessible, its removal during total knee arthroplasty can improve surgical procedures and reduce impingement of the fat pad by the prosthesis, 7 and it contains mesenchymal stromal cells. [8] [9] [10] IFP tissue removed may therefore be used for mesenchymal stromal cell recovery and have attracted interest as potential cell source for cartilage defect repair. Adipogenic, osteogenic, and chondrogenic differentiation ability of IFPSC in vitro was demonstrated by several groups. [8] [9] [10] [11] [12] [13] [14] Infrapatellar fat pad mesenchymal stromal cells (IFPSC) display similar characteristics to subcutaneous ASC from the same donor 15 ; they exert similar anti-inflammatory effects when co-cultured with synoviocytes or chondrocytes 16 ; they are able to form hyaline-like cartilage in micromass culture 11 and they maintain a stable cartilage phenotype under hydrostatic pressure. 17 Moreover, IFPSC display a superior chondrogenic potential in vitro compared to donormatched ASC from subcutaneous fat. 13 IFPSC are able to transdifferentiate in presence of autologous OA chondrocyte extracts, to form extracellular matrix onto PLGA 3D scaffolds, 10 further confirming their usefulness to repair articular surface in OA. They express superficial zone protein, a key mediator of boundary lubrication in articular joints. 18 IFPSC from OA patients possess chondrogenic capacity comparable to those isolated from patients undergoing ligament reconstruction. 19 They respond to mechanical stimulation and can be used to engineer cartilaginous grafts to resurface large damaged areas. 12 One step intrarticular injection of IFPSC was shown to be free of adverse effects in the short term and to reduce pain and improve knee function in OA patients. 20 The aforementioned characteristics of IFPSC suggest a preferential use of these cells for cartilage regeneration, but still no data are available concerning their genetic stability and biosafety after in vitro expansion (a manipulation frequently needed to obtain sufficient numbers of cells for therapy protocols). In vitro expansion was shown to induce oxidative stress, to reduce cellular replicative potential, and to promote DNA damage accumulation and cell senescence. [21] [22] [23] Mesenchymal stromal cells were shown to undergo replicative senescence, and loss of proliferation and differentiation ability upon serial passages in vitro, 24, 25 thus possibly affecting clinical applications. Moreover, in vitro cultured mesenchymal stromal cells display chromosomal aberrations, [26] [27] [28] whose biological relevance is still not clear. [29] [30] [31] Therefore, there is still concern about the biosafety of in vitro expanded mesenchymal stromal cells.
In this paper we aimed at evaluating genetic stability and replicative senescence of human IFPSC from OA patients after performance of different population doublings (PD) in culture. The availability of data concerning IFPSC genetic stability and consequently biosafety could encourage and promote their development as an efficient tool in regenerative medicine.
We performed long-term cultures of IFPSC from 11 donor samples and comparatively analyzed cells at different culture passages. Replicative senescence, possibly induced by culture expansion, was analyzed by telomere length assessment and telomerase activity quantification. Genetic stability upon in vitro culture was evaluated by microsatellite instability analysis (MSI), used as a biosafety and surrogate marker of molecular integrity. 32, 33 In parallel, Mismatch repair (MMR) gene expression was quantified. The MMR system is the main post-replicative DNA repair pathway, which guarantees genomic stability in actively proliferating cells, 34, 35 like in vitro expanded IFPSC. MMR scans and repairs mismatches occurring in the genome and its activity is mediated by protein heterodimers: MUTS (formed by MSH2-MutS Escherichia coli homolog 2-with either MSH6-MutS E. coli homolog 6-or MSH3-MutS E. coli homolog 3-) and MUTL (formed by MLH1-MutL E. coli homolog 1-with either PMS2-Postmeiotic segregation increased 2-or PMS1-Postmeiotic segregation increased 1-).
This repair system was shown to be affected both by oxidative stress (induced by culture conditions) [36] [37] [38] and by in vitro aging of precursor cells, leading to MSI. 39 In vitro transformation ability of expanded IFPSC was also evaluated.
Our results pointed to the suitability of IFPSC from OA patients for regenerative therapy approaches.
METHODS
IFPSC Culture IFP tissues (5-15 gr) were obtained from 11 OA patients undergoing total knee arthroplasty (seven men and four women, mean age AE SD: 69.4 AE 6.5 years). All donors gave their written informed consent and the study was approved by the Ethical Committee of the Rizzoli Orthopedic Institute (Protocol N. 17429). Fat was minced and digested under constant rotation at 37˚C for 30 min with 37 U/ml collagenase IA (SIGMA). Cells were then washed, filtered 100 mm and centrifuged (600g for 10 min). The SVF was plated (4 Â 10 3 cell/cm 2 ) in D-MEM (SIGMA) supplemented with 10% FBS (GIBCO), 4 mM Glutamine, Penicillin-Streptomycin 100 mg/ml and cultured at 37˚C in 5% CO 2 . Culture medium was changed twice a week until cells reached about 80% confluence. At this time point the cultures were designed as P0 (Passage 0). Subsequent subcultures were seeded at 2 Â 10 3 cells/cm 2 until 80% confluence. Cell count and viability were performed by eosin exclusion staining and morphology was monitored throughout the culture period. IFPSC were harvested at different culture passages for data analyses. Depending on the amount of recovered cells, all or only selected analyses were performed (as indicated in the respective result sections).
IFPSC Characterization
Surface Marker Profile IFPSC (1 Â 10 5 cells) resuspended in PBS, 0.2% BSA were incubated with specific FITC-or PE-conjugated antibodies or their respective controls (Pharmingen). A standard panel of adipose-derived stem cell surface positive markers (CD54, CD90, and CD105) and negative markers (CD34, CD45, CD271) was evaluated. 40 The cells were analyzed using a FACS Canto II flow cytometer (BD). Cumulative Population Doublings (CPD) were obtained by adding the PD calculated at each passage to the previous PD level.
Replication Rate

In Vitro Differentiation
Chondrogenic differentiation was induced by culture of IFPSC for 21 days in micropellet. Cells (2.5 Â 10 5 ) were pelletted in cryotubes at 740g for 10 min at 4˚C then cultured in 500 ml D-MEM (GIBCO), Penicillin-Streptomycin 100 mg/ml (GIBCO), 10% FBS (GIBCO), 4 mM Glutamine (SIGMA), 0.1 mM dexamethasone (SIGMA), 37.5 mg/ml ascorbate-2-phosphate (Wako), 1 mM sodium pyruvate (GIBCO), ITS premix (BD: 6.25 mg/ml insulin, 6.25 mg/ml transferrin, 6.25 ng/ml selenious acid, 5.35 mg/ml linoleic acid, 1.25 mg/ml BSA). Gene expression of specific markers was assessed by RT-qPCR. For osteogenic differentiation, cells were cultured at low density (3,000 cells/cm 2 ) in a-MEM (SIGMA); PenicillinStreptomycin 100 mg/ml (GIBCO), 20% FBS (GIBCO), 10 mM b-glycerophosphate (SIGMA), 0.1 mM dexamethasone (SIGMA), and 100 mM ascorbic acid (SIGMA) for 21 days. Differentiation was assessed by RT-qPCR of specific markers and by calcium-containing mineral deposit staining with Alizarin red.
Controls were represented by the same cells (same donor and same culture passage) cultured in monolayer in standard conditions.
Telomere Length Analysis IFPSC cells were treated as described. 41 Briefly, 1.5 Â 10 5 IFPSC were resuspended in hybridization buffer (70% deionized formamide, 20 mM Tris buffer pH 7.0, 1% BSA) in the presence of 2.0 mM FITC labelled (CCCTAA) 3 telomerespecific peptide nucleic acid (PNA) probe (Biosynthesis Inc.). As negative controls, samples incubated in hybridization buffer without probe were used. After denaturation for 7 min at 80˚C and hybridization for 2 h at room temperature in the dark, cells were washed and analyzed by flow cytometry (FACSCanto II with a 488 nm laser; FITC emission collected through 525/40BP; 5,000 events acquired). Telomere fluorescence was expressed as the difference between geometric mean fluorescence intensity (MFI) of cells hybridized with telomere PNA-probe and the corresponding unstained control.
Telomerase Activity Determination
Telomerase activity was quantified by the TeloTAGGG telomerase PCR Elisa Kit (ROCHE, Germany) as described. 33 Briefly, cell lysates were obtained from 2 Â 10 5 IFPSC. The hexamers added by the telomerase contained in each lysate were quantified by Elisa using TTAGGG specific probes. For each sample, relative telomerase activity (RTA) was obtained by comparison with an internal control (low control) after subtraction of the negative corresponding sample, following the formula: %RTA ¼ [(As sample À As heat-treated sample)/ As internal standard]/[(As control template À As lysis buffer)/ As internal standard]Â100 [As ¼ absorbance reading: 450 nm; reference wavelength: 690 nm].
Microsatellite Instability Analysis
Total DNA from at least 2 Â 10 5 IFPSC was extracted using the QIAamp DNA Mini Kit (Qiagen GmbH, Germany). Five microsatellite sequences interspersed in the genome (CD4, VWA, FES, TPOX, and P53) were amplified by PCR and used for MSI analysis as described. 32 Briefly, PCR products were separated on a 10% non-denaturing polyacrylamide gel and stained with Sybr green. Genotyping of each sample was performed by identification of the alleles in comparison to allelic ladders. MSI analysis was performed by checking for the appearance of additional bands or allele shifts in the allelic patterns of each IFPSC preparation at different in vitro passages.
Gene Expression Analysis
Semi-quantitative RT-PCR analysis was performed: (i) on IFPSC micromasses and cell pellets after 21 day chondrogenic and osteogenic differentiation, to test the expression of chondrogenic and osteogenic markers, respectively. Primers and PCR conditions for collagen II (COL2A1), sex determining region Y-box 9 (SOX9), runt-related transcription factor 2 (RUNX2), and alkaline phosphatase (ALP) transcripts were as described 42 ; (ii) on IFPSC recovered at different cell passages, to evaluate MMR gene expression during monolayer expansion. Primers and PCR conditions for MSH2, MSH6, MSH3, MLH1, PMS2, and PMS1 gene transcripts were as described. 43 Total RNA was extracted with Eurogold Trifast reagent (Euroclone, Italy) from homogenized micromasses and cell pellets, and reverse transcribed by random priming with the SuperScript-VILO cDNA Synthesis Kit (Invitrogen); cDNAs were amplified by real-time PCR in a LightCycler Instrument (Roche, Germany) with SYBR Premix Ex-Taq (Takara, Japan). Relative mRNA expression was obtained from Cycle threshold (C t ) values by normalization to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeeping gene, following the formula
, where E is the reaction efficiency (approximated to one because for each transcript E was >90%) and 4C t is the difference between the GAPDH and the specific C t for each sample. Expression relative to 100,000 GAPDH copies was indicated.
Soft-Agar Growth IFPSC selected samples were cultured in soft agar to test anchorage-independent colony formation, as described. 33 The soft agar colony formation assay is a well-established method to characterize the in vitro capability of cells to grow independently of a solid surface, an hallmark of cell transformation. Briefly, 3 Â 10 4 cells per sample were resuspended in 0.3% Agarose (Sigma), D-MEM, 10% FBS, and stratified on a bottom layer of 0.5% pre-solidified Agarose, then covered with 1 ml of D-MEM complete medium (each sample in duplicate). As positive and negative controls, the Saos-2 osteosarcoma cell line and wells without seeded cells were used, respectively. The presence of colonies was evaluated after 30 days culture.
Statistical Analysis
Results are expressed as mean AE standard deviation (SD) or standard error mean (SEM), as appropriate.
Data comparisons were performed by one-way Anova or Wilcoxon matched pairs test. Correlations between variables were analyzed by Kendall t test.
Tests were considered significant when p < 0.05. Statistical analysis was performed using the Statistica 6 package for Windows (StatSoft).
RESULTS
IFPSC Characterization
Cell Culture and Replication Rate Recovery from 1 gr of human IFP tissue was on average 7 Â 10 5 SVF cells. IFPSC were selected by adhesion to plastic and grown for up to about 90 days. Cells appeared throughout culture as a uniform monolayer population with a fibroblast-like morphology, slightly enlarged with culture time (Fig. 1A) . None of the cell preparations reached replicative senescence during the period of observation. Only one of the samples was cultured until P14 (corresponding to 130 days of culture and to 43.4 CPD) without showing neither proliferation arrest nor replicative senescence (not shown). Growth curves showed, as expected, a progressive deceleration of the proliferation rate with time, while maintaining a growth trend (Fig. 1B) .
Actually, proliferation rate decreased from 0.53 AE 0.30 PD/day in P0-P2 to 0.38 AE 0.1 PD/day in P8-P10 (Wilcoxon matched pairs test not significant, P0-2 vs. P8-10). Low inter-individual variability was observed in the proliferation rate except for one donor sample showing a very slow growth already from the beginning of the culture (represented by the lower line in Fig. 1B) .
After two culture passages, corresponding to about 15 days of culture, the accomplished CPD were 6.6 AE 3.1, corresponding to a proliferation rate of 0.44 AE 0.16 PD/day. After 8-10 culture passages, corresponding to about 90 days of culture, the average CPD were 29.6 AE 14.6 (36.5 AE 5.9 by excluding the sample with very slow growth), corresponding to a proliferation rate of 0.33 AE 0.17 PD/day (0.41 AE 0.1 by excluding the sample with very slow growth). No correlation was found between proliferation rate and donor age as determined by Kendall t test.
Surface Marker Profile
Surface markers were analyzed from P0 to P9 in culture. At the beginning of culture expansion (P0), IFPSC highly expressed CD54, CD90, and CD105 and, conversely, showed a very low expression of CD34, CD45, and CD271 ( Table 1) .
As concerning surface phenotype modifications with culture passages, by grouping data in three interval times corresponding to short, medium, and long-term cultures (P0-P2, P3-P5, and P6-P9, respectively) no changes among groups were observed with increasing culture passages for all the analyzed markers, as determined by one-way Anova test, thus highlighting that IFPSC maintained a stable phenotype during all the period of cell expansion (Table 2 ).
Chondrogenic and Osteogenic Differentiation Potential
Six IFPSC samples at different culture passages (from P0 to P9) were cultured in micropellets and chondrogenic medium for 21 days. In these conditions IFPSC upregulated chondrogenic markers at the mRNA level: SOX9 was significantly upregulated by average eight times (from 404. 3 
Telomere Length and Telomerase Activity
Telomere length was assessed by Flow-FISH on six donor samples at different culture passages (from P1 up to P14) and expressed as mean fluorescence intensity (MFI). By considering all samples together, a shortening trend was observed with culture time ( Fig. 2A) but without reaching statistical significance, as determined by Kendall t test, pointing to the absence of substantial telomere attrition in the observed culture period. Some variability was observed Figure 2B . Relative telomerase activity (RTA) was tested on six donor samples at different culture passages (from P0 to P14). It was completely absent or nearly undetectable (0-1.6% of the low control provided in the kit) in 75% of the samples. Two samples showed marginal activity (up to 6.0% of the low control) and other two (belonging to the same donor), showed a slightly higher telomerase activity at the beginning of the culture period: 19.97% and 30.49% relative activity (P0 and P1, respectively). This activity disappeared at P2. Telomerase activity was therefore considered overall negligible.
Microsatellite Instability MSI analysis is a PCR-based assay involving comparison of allelic profiles of microsatellite markers generated by amplification of DNA from matching samples (in this case the same donor sample DNA at different culture passages). Modifications of allele length or new alleles indicate MSI. All the 11 donor samples were tested for MSI at different culture passages (from P0 up to P12). Samples were genotyped at five microsatellite sequences and allele patterns of each donor were compared among culture passages. No MSI was detected in any donor sample at any analyzed culture passage, thus indicating that allele patterns were stably maintained in culture. This finding denotes that repeated in vitro duplications did not affect genetic stability at simple sequence repeats in the genome of IFPSC from OA patients. In Figure 3 , the allele patterns of a representative sample are shown.
Mismatch Repair Gene Expression
All 11 donor samples were analyzed for the six MMR genes, each one at different culture passages, from P0 to P12. Transcript levels of MMR genes were comparable in all samples. Mean expression levels differed among the six genes: MLH1 and MSH6 appeared the more highly expressed (mean expression relative to 100,000 GAPDH copies AE SD: 14222.7 AE 8271.6 and 4239.3 AE 2552.6, respectively). MSH2 mRNA was the less expressed (33.7 AE 29.8), whereas MSH3, PMS2, and PMS1 presented intermediate expression levels (516.5 AE 388.1; 395.2 AE 330.1; 3043.4 AE 2188.6, respectively).
The analysis of MMR gene expression in relationship to culture passages (from P0 up to P12) highlighted some modulation of transcript levels. In particular, a decrease in MSH3 expression was observed (Kendall t correlation r ¼ À0.221, p ¼ 0.005), whereas MSH2 and MSH6 mRNAs did not significantly varied (Fig. 4A) . MLH1 was not significantly modified by culture time, whereas its alternative partners PMS2 and PMS1 showed opposite behavior, with PMS2 transcript progressively decreasing (Kendall t correlation r ¼ À0.221, p ¼ 0.0054) and PMS1 progressively increasing (Kendall t correlation Data were grouped in three interval times: from P0 to P2 (P0-P2), from P3 to P5 (P3-P5), and from P6 to P9 (P6-P9). (Fig. 4B) , thus suggesting a possible shift from MLH1-PMS2 to MLH1-PMS1 heterodimer at advanced culture passages.
Soft-Agar Growth IFPSC samples from four donors, ranging from P0 to P6, were cultured in soft agar. After 30 days culture cells were unable to form colonies, thus showing they did not acquire anchorage-independent growth ability, an hallmark of transformation. On the contrary, Saos-2 positive control cells cultured in the same conditions were able to grow and form colonies (Fig. 5) .
DISCUSSION
In this study we addressed the effect of in vitro expansion on genetic stability and replicative senescence of IFPSC from knee OA patients. These preliminary analyses were intended to assess the biosafety of these cells expanded in vitro, as possible regenerative therapeutic agents. To our knowledge, no such data are already available. Recent data indicate IFPSC as an interesting candidate for cartilage regeneration. IFP constitutes a readily available and clinically achievable source of cells with chondrogenic potential [8] [9] [10] and is frequently removed during total knee arthroplasty, therefore it can be recovered and easily used. 7 IFPSC from OA patients show similar phenotype and biologic activity, but a preferential chondrogenic potential when compared to donor-matched subcutaneous ASC, 11, 13, [15] [16] [17] 19 thus looking promising for cartilage regeneration.
Since in vitro expansion is a frequently mandatory procedure to obtain a sufficient number of cells for clinical applications, we were interested in evaluating the response of IFPSC from OA patients to culture time in terms of replicative senescence and genetic stability to define a molecular biosafety profile of these cells that could be useful for their development as therapeutic agents. Safety is a major issue for regenerative medicine: in vitro expanded cells are considered as Advanced Therapy Medicinal Products and their safety must be documented before clinical use as in vitro modifications might have therapeutic consequences. In particular, genetic stability and transformation risks must be assessed. 29, 30 Similarly to bone marrow-MSC, cultured IFPSC showed a fibroblastic-like morphology, maintained until advanced culture passages. We observed no loss of proliferation ability until advanced culture times (130 days), even if with differences among donors. One donor sample showed a particularly slow growth rate since the beginning of the in vitro expansion being however indistinguishable from other samples in terms of phenotype, differentiation ability, genetic stability, and replicative senescence. This suggests a donor-dependent behavior rather than an effect of in vitro culture. Actually, proliferation rate seemed almost unaffected by culture time, indicating that expansion of IFPSC did not alter cell cycle and did not induce senescence within the interval time of observation. Reached cumulative population doublings were similar to those reported for cultured BM-MSC (about 30 PD in 100 days). 24 The IFPSC tested showed cell surface phenotype expression similar to ASC from subcutaneous fat, in accordance to literature data. 44 IFPSC were able to upregulate osteogenic and chondrogenic markers after 21 days culture in inductive media. Since differentiation ability was described as decreasing with donor age and culture time 45, 46 we induced to differentiate cells both at early (P0-1) and late (P7-9) culture passages. All samples were still able to upregulate Telomere length control and telomerase activity are two complex and dynamic processes strictly related to cell proliferation and cellular aging whose tracking appears fundamental in cellular therapy. MSC usually display low or absent telomerase activity, 47, 48 and consequently, telomeres progressively shorten along with cell divisions. 24, 49 In accordance, our results showed an almost negative telomerase activity accompanied by a shortening trend in telomere length, even 
IFPSC GENETIC STABILITY IN CULTURE
if not statistically significant, thus indicating that no substantial telomere attrition occurred. This was also observed in ASC from subcutaneous fat. 33 Negative telomerase activity is in agreement with the absence of a transformation potential of IFPSC cells.
The analysis of microsatellite instability occurrence and MMR gene expression modulation appears to be relevant for the evaluation of IFPSC biosafety after culture expansion, due to the fundamental role of the MMR system in maintaining genomic stability in proliferating cells. Moreover, the described alteration of MMR efficiency with in vitro aging 21, 22 suggests MSI as a possible marker of culture-mediated genetic instability acquisition. Finally, the stressful conditions such as oxidative stimuli present in OA tissues should be taken into consideration as possible factors influencing IFPSC stability in OA patients. In our case series, no MSI was detected even at advanced culture times, thus demonstrating that IFPSC, as ASC from subcutaneous fat, 33 maintain genomic stability of short repeated sequences in long-term cultures. This suggests a cell type-dependent susceptibility to genetic instability with in vitro aging, since different cell types showed a direct relationship between the acquisition of a MSI phenotype and in vitro/in vivo aging. 21, 39, 50 The analysis of MMR gene expression is in line with previous observations in different cellular models.
43
MSH2 and MSH6 mRNAs (the components of the principal MutS heterodimer) did not show significant variation in their expression with culture time, in accordance to the maintenance of microsatellite stability. In accordance with these results, MMR gene expression was not significantly modified in ASC from lipoaspirates, 33 whereas cells with MSI displayed a significant reduction in MMR gene expression. 43 MLH1 mRNA was also stable with time, whereas its partner PMS2 was downregulated in culture, but in the presence of a PMS1 significant upregulation. This suggests a shift from the MLH1-PMS2 heterodimer (normally the prevalent one) to the MLH1-PMS1 heterodimer as effect of culture time, without an impact on short repeated sequence stability. A progressive down-regulation of genes involved in DNA repair and metabolism were observed during in vitro culture of human MSC, 49 but this phenomenon seems not to be extended to mismatch repair genes in IFPSC cells.
Finally, soft-agar growth data are in agreement with results obtained from ASC cells from subcutaneous fat. 33 In conclusion, our data demonstrated that IFPSC from OA patients are stable after repeated duplications in vitro. Throughout culture these cells showed a substantially stable phenotype, stable morphological characteristics and stable replicative potential, without signs of replicative senescence or transformation. They also showed stability of short repeated sequences and maintenance of anchorage-dependence for their proliferation. The presented data support the suitability and safety of in vitro cultured IFPSC from osteoarthritis patients for applications in regenerative medicine approaches.
